Contineum Therapeutics, Inc. (CTNM)

NMS – Real Time Price. Currency in USD

14.89

+0.07 (0.47%)

Market open: Aug 12, 2026, 12:30 PM EDT

14.82

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

50M

Cost of goods sold

-323K

-258K

-195K

-329K

Gross Profit

-323K

-258K

50M

-329K

Operating expenses (excl. COGS)

-68M

-51M

-34M

-22M

Operating Income

-68M

-51M

16M

-23M

Non-operating income, total

-2M

Pretax income

-60M

-42M

23M

-24M

Equity in earnings

Taxes

-450K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-60M

-42M

23M

-24M

Discontinued operations

Net income

-60M

-42M

23M

-24M

Dilution adjustment

Preferred dividends

20M

Contineum Therapeutics, Inc. (CTNM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Contineum Therapeutics, Inc. (CTNM)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Contineum Therapeutics, Inc. (CTNM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Contineum Therapeutics, Inc. (CTNM)

Income Statement (Annual)

Income Statement (Annual)